Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA sitewide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference0.4%

- Check32 days agoChange DetectedThe site footer now identifies the website as running revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov site revision displayed in the footer was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedNew revision entry v3.7.0 has been added to the record history, signaling an updated version of the study record. The previous revision v3.6.6 is no longer reflected in the history, indicating that the latest update supersedes it.SummaryDifference0.1%

- Check82 days agoChange DetectedThe revision line in the page footer updated from v3.6.5 to v3.6.6, indicating a new version of the page’s revision history. This change reflects an internal update to the page without altering substantive study information.SummaryDifference0.1%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.